Scarica l'app Stockscreener
95.12
4.22%
-4.19
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ILMN Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$99.31
Aprire:
$99.51
Volume 24 ore:
1.52M
Relative Volume:
0.77
Capitalizzazione di mercato:
$14.62B
Reddito:
$4.28B
Utile/perdita netta:
$1.26B
Rapporto P/E:
12.04
EPS:
7.9
Flusso di cassa netto:
$943.00M
1 W Prestazione:
-3.85%
1M Prestazione:
-2.32%
6M Prestazione:
+12.97%
1 anno Prestazione:
-24.66%
Intervallo 1D:
$95.12
$99.51
Intervallo di 1 settimana:
$94.83
$99.56
Portata 52W:
$68.70
$156.66
Illumina Inc Stock (ILMN) Company Profile
Nome
Illumina Inc
Settore
Industria
Telefono
(858) 202-4500
Indirizzo
5200 ILLUMINA WAY, SAN DIEGO, CA
Confronta ILMN con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ILMN
Illumina Inc
|
95.12 | 14.68B | 4.28B | 1.26B | 943.00M | 7.90 |
|
TMO
Thermo Fisher Scientific Inc
|
479.46 | 179.95B | 43.21B | 6.58B | 6.17B | 17.29 |
|
DHR
Danaher Corp
|
190.05 | 137.90B | 24.01B | 3.41B | 4.86B | 4.70 |
|
IDXX
Idexx Laboratories Inc
|
641.14 | 51.04B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
123.24 | 35.19B | 6.79B | 1.22B | 1.09B | 4.26 |
|
IQV
Iqvia Holdings Inc
|
187.22 | 31.26B | 15.70B | 1.24B | 2.01B | 6.91 |
Illumina Inc Stock (ILMN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-08-12 | Downgrade | Daiwa Securities | Outperform → Neutral |
| 2025-07-11 | Downgrade | Scotiabank | Sector Outperform → Sector Perform |
| 2025-03-04 | Reiterato | Citigroup | Neutral |
| 2025-02-28 | Downgrade | HSBC Securities | Buy → Hold |
| 2025-02-10 | Downgrade | Barclays | Equal Weight → Underweight |
| 2025-02-07 | Downgrade | TD Cowen | Buy → Hold |
| 2024-12-11 | Downgrade | Citigroup | Buy → Neutral |
| 2024-11-12 | Ripresa | Morgan Stanley | Equal-Weight |
| 2024-10-17 | Aggiornamento | HSBC Securities | Hold → Buy |
| 2024-08-28 | Aggiornamento | Argus | Hold → Buy |
| 2024-08-16 | Aggiornamento | Daiwa Securities | Neutral → Buy |
| 2024-08-14 | Aggiornamento | Barclays | Underweight → Equal Weight |
| 2024-08-14 | Aggiornamento | TD Cowen | Hold → Buy |
| 2024-07-10 | Aggiornamento | Citigroup | Neutral → Buy |
| 2024-06-03 | Ripresa | Jefferies | Hold |
| 2024-01-16 | Downgrade | HSBC Securities | Buy → Hold |
| 2024-01-04 | Downgrade | TD Cowen | Outperform → Market Perform |
| 2023-12-18 | Aggiornamento | Scotiabank | Sector Perform → Sector Outperform |
| 2023-12-15 | Aggiornamento | Bernstein | Underperform → Mkt Perform |
| 2023-12-14 | Iniziato | Guggenheim | Buy |
| 2023-12-14 | Iniziato | Stephens | Overweight |
| 2023-12-13 | Iniziato | Wolfe Research | Outperform |
| 2023-12-12 | Downgrade | BofA Securities | Neutral → Underperform |
| 2023-12-11 | Aggiornamento | Citigroup | Sell → Neutral |
| 2023-11-10 | Downgrade | Canaccord Genuity | Buy → Hold |
| 2023-09-28 | Iniziato | Bernstein | Underperform |
| 2023-07-05 | Ripresa | JP Morgan | Neutral |
| 2023-01-25 | Downgrade | Argus | Buy → Hold |
| 2023-01-05 | Iniziato | Scotiabank | Sector Perform |
| 2022-12-12 | Downgrade | Citigroup | Neutral → Sell |
| 2022-12-07 | Iniziato | RBC Capital Mkts | Outperform |
| 2022-10-04 | Aggiornamento | SVB Leerink | Mkt Perform → Outperform |
| 2022-09-28 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2022-08-25 | Iniziato | Credit Suisse | Neutral |
| 2022-07-13 | Downgrade | Barclays | Equal Weight → Underweight |
| 2022-01-18 | Aggiornamento | Stifel | Hold → Buy |
| 2022-01-11 | Aggiornamento | Barclays | Underweight → Equal Weight |
| 2022-01-07 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2022-01-06 | Ripresa | Morgan Stanley | Equal-Weight |
| 2022-01-06 | Ripresa | Piper Sandler | Overweight |
| 2021-10-15 | Ripresa | Cowen | Outperform |
| 2021-08-19 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| 2021-06-01 | Aggiornamento | Evercore ISI | Underperform → In-line |
| 2021-03-31 | Downgrade | Atlantic Equities | Overweight → Neutral |
| 2021-03-31 | Aggiornamento | Canaccord Genuity | Hold → Buy |
| 2021-03-03 | Iniziato | Barclays | Underweight |
| 2020-12-22 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2020-12-17 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2020-10-13 | Downgrade | Guggenheim | Buy → Neutral |
| 2020-09-30 | Iniziato | Atlantic Equities | Overweight |
| 2020-09-29 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2020-09-22 | Downgrade | Stifel | Buy → Hold |
| 2020-09-22 | Downgrade | UBS | Buy → Neutral |
| 2020-09-21 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2020-09-21 | Downgrade | JP Morgan | Overweight → Neutral |
| 2020-09-09 | Iniziato | Morgan Stanley | Equal-Weight |
| 2020-08-07 | Downgrade | Evercore ISI | In-line → Underperform |
| 2020-08-07 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2020-07-07 | Downgrade | Guggenheim | Buy → Neutral |
| 2020-04-24 | Downgrade | Citigroup | Buy → Neutral |
| 2020-04-21 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2020-01-08 | Iniziato | Wells Fargo | Underweight |
| 2020-01-07 | Iniziato | Citigroup | Buy |
| 2020-01-02 | Downgrade | Evercore ISI | Outperform → In-line |
| 2019-11-15 | Iniziato | Stifel | Buy |
| 2019-10-25 | Iniziato | Guggenheim | Buy |
Mostra tutto
Illumina Inc Borsa (ILMN) Ultime notizie
Petrus Trust Company LTA Increases Stock Holdings in Illumina, Inc. $ILMN - MarketBeat
Royal Bank of Canada Increases Stock Holdings in Illumina, Inc. $ILMN - MarketBeat
Amundi Sells 255,844 Shares of Illumina, Inc. $ILMN - MarketBeat
Why Illumina (ILMN) Stock Is Falling Today - FinancialContent
Alliancebernstein L.P. Lowers Stake in Illumina, Inc. $ILMN - MarketBeat
Focus Partners Advisor Solutions LLC Takes Position in Illumina, Inc. $ILMN - MarketBeat
Illumina, Inc. $ILMN Shares Sold by Ion Asset Management Ltd. - MarketBeat
Astrana Health, Privia Health, Illumina, Waters Corporation, and LeMaitre Shares Plummet, What You Need To Know - Yahoo Finance
Jacobs Levy Equity Management Inc. Acquires 1,152,048 Shares of Illumina, Inc. $ILMN - MarketBeat
Europe Non-Invasive Prenatal Testing Market Growth and Company Analysis Report 2025-2033 Featuring Eurofins Scientific, F. Hoffmann-La Roche, Invitae, Illumina, Natera, Centogene, and Qiagen - Yahoo Finance
Genomic Cancer Testing Market Outlook (2025-2032) : Strategic - openPR.com
Corvex Management LP Has $303.84 Million Stock Holdings in Illumina, Inc. $ILMN - MarketBeat
Unpleasant Surprises Could Be In Store For Illumina, Inc.'s (NASDAQ:ILMN) Shares - 富途牛牛
ILMN Stock to Gain From the Launch of Illumina Protein Prep Assay - Yahoo Finance
AQR Capital Management LLC Boosts Stock Holdings in Illumina, Inc. $ILMN - MarketBeat
Illumina Launches Tool Capable of Measuring 9,500 Human Protein Targets to Support Drug Discovery - geneonline.com
Illumina (ILMN): Buy, Sell, or Hold Post Q2 Earnings? - FinancialContent
Illumina Launches Protein Prep Tool Capable of Measuring 9,500 Human Protein Targets - geneonline.com
Maverick Capital Ltd. Raises Stake in Illumina, Inc. $ILMN - MarketBeat
Illumina Launches Tool to Measure 9,500 Human Protein Targets for Proteomic Research - geneonline.com
Real time social sentiment graph for Illumina Inc2025 Trading Recap & Fast Exit and Entry Strategy Plans - Newser
Brokerages Set Illumina, Inc. (NASDAQ:ILMN) Price Target at $123.17 - MarketBeat
Should I add Illumina Inc. stock to my portfolioJuly 2025 Trends & Scalable Portfolio Growth Ideas - خودرو بانک
Canada Pension Plan Investment Board Trims Holdings in Illumina, Inc. $ILMN - MarketBeat
Top chart patterns to watch in Illumina Inc.Weekly Trend Summary & Real-Time Stock Price Movement Reports - Newser
BNP Paribas Financial Markets Increases Position in Illumina, Inc. $ILMN - MarketBeat
Using AI based signals to follow Illumina Inc.Portfolio Update Summary & Stepwise Entry/Exit Trade Alerts - Newser
How sensitive is Illumina Inc. to inflationWeekly Volume Report & Consistent Growth Stock Picks - خودرو بانک
Aug Summary: Should I set a stop loss on Illumina Inc.Trade Volume Report & Daily Price Action Insights - خودرو بانک
Pattern recognition hints at Illumina Inc. upsideJuly 2025 Outlook & Growth Oriented Trade Recommendations - Newser
Ranking Illumina Inc. among high performing stocks via toolsQuarterly Risk Review & Low Drawdown Trading Strategies - Newser
Will Illumina Inc. continue its uptrendPortfolio Value Summary & Weekly Chart Analysis and Trade Guides - Newser
Using data filters to optimize entry into Illumina Inc.Earnings Risk Summary & Safe Entry Zone Tips - Newser
Will Illumina Inc. benefit from macro trends2025 Trade Ideas & Technical Buy Zone Confirmations - Newser
Real time breakdown of Illumina Inc. stock performanceWeekly Profit Recap & Weekly Breakout Watchlists - Newser
Illumina Inc. stock prediction for this weekGlobal Markets & High Accuracy Swing Entry Alerts - Newser
Can you recover from losses in Illumina Inc.2025 Trading Recap & Low Risk High Reward Ideas - Newser
Illumina Ventures cuts target for third fund - Global Venturing
What to expect from Illumina Inc. in the next 30 daysJuly 2025 Opening Moves & Intraday High Probability Alerts - Newser
Wellington Management Group LLP Purchases 11,915 Shares of Illumina, Inc. $ILMN - MarketBeat
Can Illumina Inc. hit a new high this monthWeekly Trend Summary & Target Return Focused Picks - Newser
Illumina Inc. Stock Underperforms Wednesday When Compared To Competitors - 富途牛牛
Illumina® Protein Prep launches to drive greater proteomic insights for improved drug discovery and development - Illumina
What momentum shifts mean for Illumina Inc.2025 Key Highlights & Capital Protection Trading Alerts - Newser
Will Illumina Inc. stock recover after recent drop2025 Geopolitical Influence & Weekly Breakout Watchlists - Newser
What’s the fair value of Illumina Inc. stockJuly 2025 Weekly Recap & Long-Term Safe Investment Ideas - خودرو بانک
Carl Icahn Exits Dana And Illumina: Capital Redeployment Signals Portfolio Repositioning - The Acquirer's Multiple
Illumina, Inc. $ILMN Stake Lessened by Tema Etfs LLC - MarketBeat
What the charts say about Illumina Inc. todayPortfolio Return Summary & Long-Term Capital Growth Ideas - Newser
Illumina Protein Prep: Revolutionizing Proteomics to Accelerate Drug Discovery and ROI for Biopharma - AInvest
Illumina Protein Prep launches to drive greater proteomic insights for improved drug discovery and development - MarketScreener
Illumina Inc Azioni (ILMN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.33%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):